论文部分内容阅读
本研究检测了药物负荷超声心动图用于对年龄≥65岁患者进行风险分层的价值。研究纳入了2160例年龄≥65岁的患者(1257例男性,年龄71±5岁),接受双嘧达莫(n=1521)或多巴酚丁胺(n=639)负荷超声心
This study examined the value of drug load echocardiography for risk stratification in patients ≥65 years of age. The study enrolled 2160 patients (1257 men, age 71 ± 5 years) ≥65 years of age undergoing ambulatory echocardiography of dipyridamole (n = 1521) or dobutamine (n = 639)